Up and running again

A Boston Scientific therapy helped Esther overcome cancer pain.

Read her story

Featured stories
Nov 22, 2024
A groundbreaking advance in treating erectile dysfunction: the TENACIO™ Pump

Learn how the pump, and penile prosthesis implants, work.

Oct 30, 2024
3 ways leaders can create a culture of innovation

Turning a great idea into reality doesn’t happen in a vacuum. It requires a strong company culture.

Oct 28, 2024
4 things to know about our acquisition of Silk Road Medical

This acquisition will enable us to reach more of the millions of people at risk of stroke around the world. Learn how.

Read more stories

Press releases
Nov 25, 2024
Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc.

Acquisition to expand interventional oncology offerings with complementary therapy to treat liver-dominant metastases MARLBOROUGH, Mass., Nov. 25, 2024 /PRNewswire/ -- Boston Scientific...

Nov 16, 2024
Boston Scientific WATCHMAN FLX™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial

Data also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation following a cardiac ablation MARLBOROUGH, Mass. and...

Nov 15, 2024
Boston Scientific Closes Acquisition of Axonics, Inc.

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a medical technology company focused on the development and...

Read more press releases

In the news
Nov 12, 2024
Its stock is up 50 percent. Billion-dollar deals for breakfast. How did Boston Scientific get its mojo back?
The Boston Globe
Through interviews with senior executives and industry analysts, The Boston Globe explores how the combination of Boston Scientific’s acquisition strategy, in-house R&D and investment portfolio position the company for long-term success.
Sep 17, 2024
Boston Scientific closes Silk Road Medical acquisition
Mass Device
Boston Scientific has completed its $1.18 billion acquisition of Silk Road Medical, adding the TCAR stroke-prevention platform to its vascular portfolio to enhance patient outcomes and expand its minimally invasive treatment options.
Sep 12, 2024
Shaping the future of real-world evidence and AI in healthcare
MedTech Intelligence
Dr. Ken Stein, senior vice president and global chief medical officer, illustrates AI’s potential to enable more personalized care, especially through wearable devices and home-based health monitoring.
Sep 7, 2024
Untapped talent: Unlocking the potential of overlooked people
HR Quarterly
Camille Chang Gilmore, vice president of human resources and global chief diversity officer, shares our commitment to developing a workforce that is reflective of the patients and communities we serve, inclusive of individuals with disabilities.

Read more news

2023 Performance Report

When science, humanity and purpose connect, lives can be transformed

View the Report

News alerts

Sign up to receive our press releases via email

Media contacts

Business and enterprise contacts for journalists

Media resources

Imagery and other resources

Top